+44 1223 790975Journal of Genetic Syndromes & Gene Therapy : Citations & Metrics Report
Articles published in Journal of Genetic Syndromes & Gene Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Genetic Syndromes & Gene Therapy has got h-index 23, which means every article in Journal of Genetic Syndromes & Gene Therapy has got 23 average citations.
Following are the list of articles that have cited the articles published in Journal of Genetic Syndromes & Gene Therapy.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
Year wise published articles |
25 | 8 | 2 | 1 | 8 | 40 |
Year wise citations received |
174 | 175 | 203 | 181 | 251 | 250 |
| Journal total citations count | 2102 |
| Journal impact factor | 5.89 |
| Journal 5 years impact factor | 13.25 |
| Journal cite score | 20.22 |
| Journal h-index | 23 |
| Journal h-index since 2018 | 16 |
Important citations (187)
doerfler pa, nayak s, corti m, morel l, herzog rw, et al. (2016) targeted approaches to induce immune tolerance for pompe disease therapy. molecular therapy-methods & clinical development 3: 15053. |
|
qu w, wang m, wu y, xu r (2015) scalable downstream strategies for purification of recombinant adeno-associated virus vectors in light of the properties. current pharmaceutical biotechnology 16: 684-95. |
|
liu cl, ye p, lin j, butts cl, miao ch (2015) anti-cd20 as the b-cell targeting agent in a combined therapy to modulate anti-factor viii immune responses in hemophilia a inhibitor mice. immune responses to aav vectors, from bench to bedside 30: 70. |
|
sherman a, schlachterman a, cooper m, merricks ep, raymer ra, et al. () portal vein delivery of viral vectors for gene therapy for hemophilia. gene correction: methods and protocols 2014: 413-426. |
|
zolotukhin i, luo d, gorbatyuk os, hoffman be, warrington jr kh, et al. (2013) improved adeno-associated viral gene transfer to murine glioma. journal of genetic syndrome & gene therapy 4. |
|
mitchell am, samulski rj (2013) mechanistic insights into the enhancement of adeno-associated virus transduction by proteasome inhibitors. journal of virology. 87: 13035-13041. |
|
rogers gl, herzog rw (2015) gene therapy for hemophilia. frontiers in bioscience (landmark edition) 20: 556. |
|
wang d, zhong l, nahid ma, gao g (2014) the potential of adeno-associated viral vectors for gene delivery to muscle tissue. expert opinion on drug delivery 11: 345-64. |
|
aleksejeva i (2013) use of genetically modified organisms in food production and future challenges. ineconomic science for rural development conference proceedings. |
|
stueber d, marvasti-sitterly m, fitch k (2012) cost benefit analysis of gmo corn in nepal. |
|
kienle ec secrets to finding the ideal mate: new insights into parameters that govern successful adeno-associated virus (aav) vector evolution (doctoral dissertation). |
|
pankajakshan d, agrawal dk (2013) clinical and translational challenges in gene therapy of cardiovascular diseases. intech open access publisher. |
|
fuller td, spracklen cn, ryckman kk, knake la, busch td,et al. accepted article preview: published ahead of advance online publication. |
|
anderson cd, moisyadi s, avelar a, walton cb, shohet rv (20163). ultrasound-targeted hepatic delivery of factor ix in hemophiliac mice. gene therapy. |
|
george la, fogarty pf (2016). gene therapy for hemophilia: past, present and future. inseminars in hematology 53: 46-54. |
|
scott dw (2014) inhibitors–cellular aspects and novel approaches for tolerance. haemophilia. 20: 80-6. |
|
rogers gl, herzog rw (2015) gene therapy for hemophilia. frontiers in bioscience (landmark edition). 20: 556. |
|
scott dw, pratt kp, miao ch (2013) progress toward inducing immunologic tolerance to factor viii. blood 121: 4449-56. |
|
high kh, nathwani a, spencer t, lillicrap d (2014. current status of haemophilia gene therapy. haemophilia 20: 43-9. |
|
mingozzi f, high ka (2013) immune responses to aav vectors: overcoming barriers to successful gene therapy. blood 122: 23-36. |
|